logo
Share SHARE
FONT-SIZE Plus   Neg

AstraZeneca: FDA Issues Complete Response Letter For ZS-9 - Quick Facts

AstraZeneca (AZN.L) announced the US FDA has issued a Complete Response Letter regarding the New Drug Application (NDA) for ZS-9 (sodium zirconium cyclosilicate). The CRL followed an inspection by the FDA of the ZS-9 manufacturing facility. The CRL does not require the generation of any new clinical data.

Sodium zirconium cyclosilicate is being developed for the treatment of hyperkalaemia by ZS Pharma, a subsidiary of AstraZeneca.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Facebook Inc. has acquired anonymous social networking app tbh for an undisclosed sum and plans to operate it as a standalone app. The acquisition is part of Facebook's efforts to appeal to teenagers. Techcrunch reported that Facebook paid less than $100 million for the acquisition and the deal will not require any regulatory approval. Cruise itineraries in the Caribbean islands are almost back to business after the hurricanes Irma and Maria blasted through some islands. The Florida-Caribbean Cruise Association announced on a press call Monday that the hardest hit major ports, St. Thomas and St. Croix in the U.S. Virgin Islands, and St. Maarten and San Juan, Puerto Rico, are expected to open by the end of November. Banking major Goldman Sachs Group Inc. (GS) reported Tuesday profit for the third-quarter that declined 3 percent from last year. But, quarterly net revenues increased 2 percent. Both earnings per share and revenues topped analysts' expectations.
comments powered by Disqus
Follow RTT